Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
Hims & Hers Health offers GLP-1 weight loss drugs at a fraction of the cost of brand-name competitors, leading to a significant increase in shares. [ more ]
Lots of drug companies talk about putting patients first but this one actually did
Key Takeaway: Amylyx Pharmaceuticals voluntarily pulled their ALS drug from the market after a study revealed it wasn't effective, demonstrating commitment to integrity and ethics. [ more ]
Cost of developing new drugs may be far lower than industry claims, trial reveals
The true cost of developing medicine may be far less than estimated by the pharmaceutical industry, sparking the need for transparency in clinical trial spending. [ more ]
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors
The public disclosure of human clinical trials may potentially lead to the invalidation of pharmaceutical patents, causing concerns for pharmaceutical innovators. [ more ]
France rides AI wave to secure 15B in foreign investment
France secured a record â¬15bn in foreign investment from companies like Microsoft and Amazon at the Choose France summit, highlighting the country's economic allure. [ more ]
Health marketing M&A in good shape with 28 notable deals completed
Healthcare marketing is attractive to investors due to the necessity nature of medical purchases and the significant size of pharma marketing budgets. [ more ]
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
California is partnering with a pharmaceutical company to purchase generic Narcan at a lower cost, expanding access to naloxone for opioid overdose treatment. [ more ]
Drug shortages in the US reach record highs, impacting over 300 essential medications. Civica Rx offers a successful model for addressing shortages. [ more ]
The battle over prescription drug prices is heating up
The Inflation Reduction Act (IRA) shifts power from American drug companies to the government through Medicare price negotiations.
The IRA's drug price negotiations will be implemented in phases, with 10 drugs covered under Medicare Part D targeted for the first round of negotiations. [ more ]
Trump embraces conspiratorial language to attack Big Pharma
Donald Trump is now suggesting that the pharmaceutical industry's products may be harming Americans, particularly children.
His unfounded claims about the pharmaceutical industry could undermine public health and reflect the deep mistrust of health institutions within the Republican party. [ more ]
Bernie Sanders on What Americans Need to Understand About Big Pharma
Senator Bernie Sanders is preparing to grill the CEOs of three major pharmaceutical companies over high drug prices.
The median launch price of innovative prescription drugs has increased significantly in recent years, according to a report by the Senate HELP committee. [ more ]
Pharma Bro Martin Shkreli Lashes Out At Second Circuit Because Consequences Are Hard
Martin Shkreli's appeal to overturn his lifetime ban from the pharmaceutical industry and $64.6 million disgorgement has been rejected by the Second Circuit.
Shkreli is the first individual in US history to be sued under the Sherman Act Section 2 as a monopolist. [ more ]